tiprankstipranks
Avalo Therapeutics (AVTX)
NASDAQ:AVTX
US Market
AVTX
Avalo Therapeutics
RESEARCH TOOLSreports
Want to see AVTX full AI Analyst Report?

Avalo Therapeutics (AVTX) Income Statement

1,059 Followers

Avalo Therapeutics Income Statement

Last quarter (Q4 2025), Avalo Therapeutics's total revenue was $59.00K, a decrease of -69.27% from the same quarter last year. In Q4, Avalo Therapeutics's net income was $-13.72M. See Avalo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 59.00K$ 441.00K$ 1.92M$ 18.05M$ 5.40M
Gross Profit
$ -285.00K$ 807.00K$ 640.00K$ 14.62M$ 3.91M
Operating Expenses
$ 72.98M$ 69.32M$ 27.99M$ 52.06M$ 86.04M
Depreciation and Amortization
$ 344.00K$ 169.00K$ 158.00K$ 166.00K$ 1.66M
EBITDA
$ -72.92M$ -68.34M$ -23.29M$ -37.27M$ -80.48M
Operating Income
$ -72.92M$ -68.51M$ -27.35M$ -37.44M$ -82.13M
Other Income/Expenses
$ -5.17M$ 33.50M$ -4.18M$ -4.19M$ -2.41M
Pretax Income
$ -78.09M$ -35.02M$ -31.53M$ -41.63M$ -84.55M
Net Income
$ -78.26M$ -35.13M$ -31.54M$ -41.66M$ -84.38M
Per Share Metrics
Basic EPS
$ -5.84$ -4.32$ -113.58$ -1.06K$ -2.33K
Diluted EPS
$ -5.84$ -3.26$ -113.58$ -1.06K$ -2.33K
Weighted Average Shares Outstanding
 13.40M 8.13M 277.73K 39.20K 36.19K
Weighted Average Shares Outstanding (Diluted)
 13.40M 10.78M 277.73K 39.20K 36.19K
Currency in USD

Avalo Therapeutics Earnings and Revenue History